Search

METEOR’s search works in a similar way to other search engines. You can use keywords or terms to pull up related content. The below tips are specific to METEOR and will help you to find what you need.

Try searching using either a keyword, specific term or METEOR ID number.

METEOR ID search

If you’re a returning user and know an item’s METEOR ID, you can enter it in the search box. Clicking the search icon will take you straight to the item’s page.

Autocomplete

METEOR will automatically display suggestions for search terms as you’re typing. This predictive text will show you METEOR entries that exist for the topic you’re searching on. You don’t have to use any of these suggestions, but they may make your searching process faster and easier.

Pressing ‘tab’ will select the top suggestion. Otherwise, selecting from the list of suggestions will put the suggested search term into the search box. You can then click the search icon to find related content. Clicking anywhere on the search results will take you to the item’s page.

Spelling correction

METEOR will show search results with spelling correction. Misspelled terms can still be selected for search where relevant.

Dropdown options

The drop-down menus directly below the search text box allow you to limit the search results to any of the 18 content types in METEOR (see Learn about metadata to view the list), by item creation dates, and item revision dates.

Content types

Content types allow you to limit your search to various metadata building blocks and other topic or help content found in METEOR. See Learn about metadata to view a list of metadata item types that you can search in METEOR. Searching on Topic pages will give results from METEOR’s ‘non-metadata’ pages which explain metadata, how it is managed, how to use METEOR, and how to develop metadata.

Searching on Help will give results from all the pop-up information boxes that are linked to each metadata item. The Help search looks through all text from the METEOR Business Rules, which is accessed through the small ‘i’ icon used throughout the site.

Created date and Revision date

The Created and Revision date dropdown options limit your search to when an item was created or last revised. METEOR will search any time by default, or you can select or specify a custom period.

Custom search syntax

METEOR uses Lucene search syntax. This functionality can be useful to fine-tune your search results even more. Some of the commands include:

  1. Restrict search to the titles of items by using Name: Searchterm. Note that it has to be written exactly as Name, with the capital N. Using name will not work. It doesn’t matter if there’s a space around the colon or not.
  2. Force a second term to be included by using AND.
  3. Widen your search to include another option using the term OR.

For example, if you’re looking for something with the word ‘baby’ in the title you would use Name: baby. METEOR will also give you results for the plural of the search term, so if you search on ‘baby’ you will also get results for ‘babies’. If looking for something with two terms (‘baby’ and ‘admission’) you would use Name: baby AND admission.

Sort by

You can also display your search results with a range of options in the Sort by drop-down menu on the right. You can sort on Relevance, Most/Least Recently Created, Most/Least Recently Updated, and Alphabetically (A–Z and Z–A).

Clear

The Clear button resets the Search page.

Filtering search results

You can fine-tune your search results using the filters that appear in the left-hand menu after searching any term. These filters are dynamic and will only display options specific to your search term, for example, only registration authorities relating to your search term will be displayed. You can use multiple filters at once.

Some of the filters change depending on your role within METEOR. If you are using METEOR without an account, you can search on metadata item type, public registration statuses, METEOR ID, and registration authority. You are also able to compare two items.

If you are using METEOR without an account, you will not be able to save bookmarks for items you’re interested in. There are also some non-public registration statuses that you won’t be able to see.

If you wish to save bookmarks, you can sign up for a free METEOR account easily, just follow the Sign up now prompts after clicking on the Sign In button. If you have an account, you will also be able to subscribe to notifications about changes to specific items in METEOR.

If you are logged in to METEOR as a metadata developer, or any other official role, there are some additional search options. You will be able to restrict your search to the full range of registration status options, including non-public statuses. You will also be able to save bookmarks and subscribe to notifications about changes to items.

Each search result has a small ‘hamburger’ icon on the right . This gives you download links for the metadata item as a PDF or a Word document.


Search

Showing 301-400 of 423 results
Prev 1 2 3 5 Next
Page size:
Number of people dispensed five or more medicines per 100,000 people aged 75 years and over, 2018-19

726365 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Number of people who had at least one medication management review, per 100,000 people aged 75 years and over, 2018-19

726134 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Number of potentially preventable hospitalisations - cellulitis per 100,000 people of all ages, 2014-15 to 2017-18

724500 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Number of potentially preventable hospitalisations - chronic obstructive pulmonary disease (COPD) per 100,000 people of all ages, 2014-15 to 2017-18

724575 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Number of potentially preventable hospitalisations - diabetes complications per 100,000 people of all ages, 2014-15 to 2017-18

724543 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Number of potentially preventable hospitalisations - heart failure per 100,000 people, of all ages, 2014-15 to 2017-18

724516 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Number of potentially preventable hospitalisations - kidney and urinary tract infections per 100,000 people of all ages, 2014-15 to 2017-18

724486 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 2a - Proportion of patients who received opioid analgesics who had pain and functional assessments prior to being prescribed opioid analgesics

755547 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 3a - Proportion of patients separated from hospital with a supply or prescription of opioid analgesics where a Real Time Prescription Monitoring program or prescription shopping program was checked prior to separation

755550 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 3b - Proportion of patients who were newly prescribed opioid analgesics who were co-prescribed central nervous system depressant medicines while in hospital

755552 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 4a - Evidence of a locally approved policy that defines the process for managing admitted patients identified as being at increased risk of opioid-related harm who are prescribed an opioid analgesic

755556 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 5a - Proportion of patients that separated from hospital with a supply or prescription of opioid analgesics who also received a supply or prescription of paracetamol and non-steroidal anti-inflammatory medicines

755558 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 5b - Proportion of opioid-naïve surgical patients separated from hospital with a supply or prescription of opioid analgesics where the supply or prescription was for a modified-release formulation

755561 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 6a - Proportion of admitted patients who received opioid analgesics who were administered naloxone for respiratory depression

755563 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 6b - Proportion of admitted patients who received opioid analgesics who also received laxatives to prevent opioid-induced constipation

755566 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 7a - Proportion of admitted patients who received opioid analgesics where the intended number of days of treatment was documented in their medical record

755568 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 8a - Proportion of overnight admitted patients separated from hospital with a supply or prescription of opioid analgesics that exceeded the opioid analgesic inpatient dose given during the 24 hrs prior to separation

755570 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 9a - Evidence of a locally approved policy to support the transfer of care of patients who separate from hospital with a supply or prescription of opioid analgesics

755572 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 9b - Proportion of admitted patients separated from hospital with a supply or prescription of opioid analgesics where the supply or prescription exceeded 7 days of treatment

755574 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 9c - Proportion of patients separated from the emergency department with a supply or prescription of opioid analgesics where the supply or prescription exceeded 3 days of treatment

755576 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 9d - Proportion of patients separated from hospital with a supply or prescription of opioid analgesics whose medication management plan was given to the patient or carer on separation

755578 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Opioid analgesic stewardship: 9e - Proportion of patients separated from hospital with a supply or prescription of opioid analgesics whose medication management plan was sent to the general practitioner on separation

755580 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Orthogeriatric model of care

628052 | Outcome Area | Australian Commission on Safety and Quality in Health Care
A patient with a hip fracture is offered treatment based on an orthogeriatric model of care as defined in the Australian and New Zealand guideline for hip fracture care (ANZHFR Steering Group 2014).
Standard: Health

Osteoarthritis

644538 | Glossary Item | Australian Commission on Safety and Quality in Health Care
A clinical syndrome of joint pain accompanied by varying degrees of functional limitation and reduced quality of life. Pain, reduced function and effects on a person’s ability to carry out their day-to-day activities can be important consequences. Osteoarthritis is characterised pathologically by localised loss of articular cartilage (cartilage lining the articular ends of the bones), as well as changes to bone and other joint structures and associated inflammation.
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 1a-Local arrangements to ensure that patients newly diagnosed with knee osteoarthritis have a comprehensive assessment

644252 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 1b-Proportion of patients newly diagnosed with knee osteoarthritis who have a comprehensive assessment

644266 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 2a-Local arrangements for clinically based diagnosis of knee osteoarthritis without use of imaging for people with knee pain and other symptoms suggestive of osteoarthritis

644277 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 2b-Proportion of patients clinically diagnosed with knee osteoarthritis, without imaging

644279 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 3-Proportion of patients newly diagnosed with knee osteoarthritis who have an individualised self-management plan

644285 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 4a-Proportion of patients newly diagnosed with knee osteoarthritis with a documented recommendation regarding regular exercise

644289 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 4b-Proportion of patients with knee osteoarthritis who were overweight or obese who lost weight

644293 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 5a-Local arrangements to ensure that patients with knee osteoarthritis are prescribed or recommended medicines in accordance with the current Therapeutic guidelines: Rheumatology

644306 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 5b-Proportion of patients with knee osteoarthritis prescribed oral non-steroidal anti-inflammatory drugs (NSAIDs) with documented assessment of risks

644304 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 5c-Proportion of patients prescribed opioids for longer than three months for the management of pain associated with knee osteoarthritis

644310 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 6a-Proportion of patients with knee osteoarthritis with an agreed date for a review

644312 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 6b-Proportion of patients with knee osteoarthritis with evidence of pain and function assessments within the previous 12 months

644314 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 6c-Proportion of patients with knee osteoarthritis who have documented pain level reduction of at least 20%, 12 months after initiation or change of treatment

644316 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 6d-Proportion of patients with knee osteoarthritis with a functional limitation who have a 10% or greater improvement in function 12 months after initiation or change of treatment

644320 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 7a-Number of patients undergoing arthroscopic procedures for knee osteoarthritis

644337 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 7b-Proportion of patients with knee osteoarthritis referred for consideration of surgery who were supported with non-surgical core treatments for at least three months

644349 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Osteoarthritis of the knee clinical care standard indicators: 8-Local arrangements to ensure that patients’ experience of the care that they receive for knee osteoarthritis is regularly measured and acted upon

644358 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Health

Pain management

628050 | Outcome Area | Australian Commission on Safety and Quality in Health Care
A patient with a hip fracture is assessed for pain at the time of presentation and regularly throughout their hospital stay, and receives pain management including the use of multimodal analgesia, if clinically appropriate.
Standard: Health

Patient episode of Staphylococcus aureus bloodstream infection

752230 | Object Class | Australian Commission on Safety and Quality in Health Care
An episode of healthcare-associated Staphylococcus aureus bloodstream infection (SABSI) that arises from an episode of admitted patient care in an Australian hospital.
Standard: Health

Patient episode of Staphylococcus aureus bloodstream infection—infection setting

752249 | Data Element Concept | Australian Commission on Safety and Quality in Health Care
The environment in which a patient episode of Staphylococcus aureus bloodstream infection (SABSI) was acquired.
Standard: Health

Patient episode of Staphylococcus aureus bloodstream infection—infection setting, origin code N

752253 | Data Element | Australian Commission on Safety and Quality in Health Care
The environment in which a patient episode of Staphylococcus aureus bloodstream infection (SABSI) was acquired, as represented by a code.
Standard: Health

Patient episode of Staphylococcus aureus bloodstream infection—most probable origin

752238 | Data Element Concept | Australian Commission on Safety and Quality in Health Care
The most probable source of a patient episode of Staphylococcus aureus bloodstream infection.
Standard: Health

Patient episode of Staphylococcus aureus bloodstream infection—most probable origin, healthcare associated clinical criteria code N

752242 | Data Element | Australian Commission on Safety and Quality in Health Care
The most probable healthcare associated source of a patient episode of Staphylococcus aureus bloodstream infection, as represented by a code.
Standard: Health

Patient episode of Staphylococcus aureus bloodstream infection—Staphylococcus aureus methicillin susceptibility indicator

752256 | Data Element Concept | Australian Commission on Safety and Quality in Health Care
An indicator of whether the Staphylococcus aureus bloodstream infection (SABSI) isolate is susceptible to oxacillin or methicillin (cefoxitin) in a patient episode of Staphylococcus aureus bloodstream infection.
Standard: Health

Patient episode of Staphylococcus aureus bloodstream infection—Staphylococcus aureus methicillin susceptibility indicator, yes/no code N

752267 | Data Element | Australian Commission on Safety and Quality in Health Care
An indicator of whether the Staphylococcus aureus bloodstream infection (SABSI) isolate is susceptible to oxacillin or methicillin (cefoxitin) in a patient episode of Staphylococcus aureus bloodstream infection, as represented by a code.
Standard: Health

Person—Indigenous status, code N

723676 | Data Element | Australian Commission on Safety and Quality in Health Care
Whether a person identifies as being of Aboriginal or Torres Strait Islander origin, as represented by a code.
Standard: Australian Commission on Safety and Quality in Health Care

Person—specimen collection time, hhmm

754348 | Data Element | Australian Commission on Safety and Quality in Health Care
The time at which the specimen was collected from the person, presented in 24 hour time.
Standard: Health

Person—specimen collection time, hhmm

438491 | Data Element | Australian Commission on Safety and Quality in Health Care
The time at which the specimen was collected from the person, presented in 24 hour time.
Superseded: Health

Preventing falls and pressure injuries

624405 | Outcome Area | Australian Commission on Safety and Quality in Health Care
A patient with delirium is provided with care based on their risk of falls and pressure injuries.
Standard: Health

Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard 2024

791005 | Indicator Set | Australian Commission on Safety and Quality in Health Care
The Australian Commission on Safety and Quality in Health Care has developed these indicators to support clinicians, healthcare and aged care organisations to monitor implementation of the care described in the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (ACSQHC 2024). The indicators included in this specification are a tool to support local clinical quality improvement and may be used to support other quality assurance and peer review activities.The Psych...
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 2a- Proportion of people with cognitive disability or impairment who were prescribed psychotropic medicine for whom informed consent was obtained and documented

791012 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic Medicines: 3a-Evidence of local arrangements to ensure a person with cognitive disability or impairment with behaviours of concern is assessed to identify any clinical, psychosocial and environmental causes for the behaviours

791014 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 4a- Evidence of local arrangements to ensure people with cognitive impairment or disability receive appropriate non-medication strategies to prevent or reduce behaviours of concern

791016 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 5a- Evidence of a local policy to ensure a person’s behaviour support plan is used to support their care

791018 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 6a- Proportion of people with cognitive disability or impairment who were prescribed psychotropic medicine for whom the reason(s) for prescribing the medicine was documented in their healthcare record

791020 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 6b-Proportion of people with cognitive disability or impairment who were prescribed psychotropic medicine for behaviours of concern who had a comprehensive assessment to identify factors that might be contributing to the behaviours

791022 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 6c- Proportion of people with cognitive disability or impairment who were prescribed psychotropic medicine for behaviours of concern who were also receiving non-medication strategies

791024 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 7a- Proportion of people with cognitive disability or impairment who were prescribed psychotropic medicine for whom the timeframe to review the medicine was documented in their healthcare record

791026 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 7b- Proportion of people with cognitive disability or impairment who were prescribed a psychotropic medicine for whom the effectiveness of the medicine on target symptoms and any adverse effects were documented at each review

791028 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic Medicines: 8a-Evidence of a locally approved policy to ensure that information about a person’s behaviour support needs and their psychotropic medicines is transferred with the person between care settings

791030 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 8b- Proportion of people with cognitive disability or impairment discharged with a supply or prescription for psychotropic medicine where the person or support people were provided with information about the medicine on discharge

791032 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 8c- Proportion of people with cognitive disability or impairment who were prescribed psychotropic medicine while in hospital, whose discharge information was sent to the clinician responsible for their care, on discharge

791034 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Psychotropic medicines: 8d- Proportion of people with cognitive disability or impairment who were prescribed psychotropic medicine while in hospital, whose discharge information was sent to their aged care or disability service provider on discharge

791036 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Pulmonary embolism

697221 | Glossary Item | Australian Commission on Safety and Quality in Health Care
A blood clot that breaks off from the deep veins and travels round the circulation to block the arteries in the lung (pulmonary arteries). Most deaths arising from deep vein thrombosis are caused by pulmonary embolism (NICE 2015).
Standard: Australian Commission on Safety and Quality in Health Care

Risk stratification

624374 | Outcome Area | Australian Commission on Safety and Quality in Health Care
A patient with a non-ST-segment-elevation acute coronary syndrome (NSTEACS) is managed based on a documented, evidence-based assessment of their risk of an adverse event.
Standard: Health

Screening for cognitive impairment

624386 | Outcome Area | Australian Commission on Safety and Quality in Health Care
A patient presenting to hospital with one or more risk factors for delirium is screened for cognitive impairment using a validated test.
Recorded: Health

Sepsis clinical care standard indicators: 1a-Proportion of patients with suspected sepsis who had blood lactate levels taken as a part of screening for sepsis

755592 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 2a-Evidence of a locally approved sepsis clinical pathway

755595 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 2b-Evidence of local arrangements that support the delivery of care described in the local sepsis clinical pathway

755597 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 2c-Proportion of patients with sepsis who were treated according to the locally approved sepsis clinical pathway

755642 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 3a-Proportion of patients with sepsis who had blood cultures taken prior to starting antimicrobials

755644 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 3b-Proportion of patients with signs and symptoms of infection-related organ dysfunction who started their first dose of an empirical antimicrobial within 60 minutes of recognition

755646 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 4a-Evidence of local arrangements to support multidisciplinary care coordination and clinical communication for patients with sepsis

755652 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 5a-Proportion of patients with sepsis who reported they were kept informed as much as they wanted about their treatment and care

755654 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 6a-Proportion of patients with sepsis who had a diagnosis of sepsis recorded in their discharge summary

755656 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 7a-Proportion of patients with sepsis who had an unplanned readmission to any hospital within 30 days of discharge

755658 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Sepsis clinical care standard indicators: 8a-Proportion of patients with sepsis who died during their admitted patient episode of care

755660 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Severe sepsis (Antimicrobial stewardship clinical care standard)

629064 | Glossary Item | Australian Commission on Safety and Quality in Health Care
For the purposes of the Antimicrobial stewardship clinical care standard (ACSQHC 2014), severe sepsis is the systematic response to an infection manifested by organ dysfunction, hypoperfusion or hypotension combined with one or more of the following: fever, tachypnoea, elevated white cell count (Antibiotic Expert Groups 2014).
Standard: Health

Specimen collection date

428405 | Property | Australian Commission on Safety and Quality in Health Care
The date on which the sample of a substance or material, for example, tissue, blood or urine, was collected for diagnostic examination or evaluation.
Standard: Health

ST-segment-elevation myocardial infarction (STEMI) (Acute coronary syndromes clinical care standard)

629401 | Glossary Item | Australian Commission on Safety and Quality in Health Care
For the purposes of the Acute coronary syndromes clinical care standard (ACSQHC 2014), an ST-segment-elevation myocardial infarction (STEMI) is one type of acute coronary syndrome. It is when a myocardial infarction is prolonged, leading to more severe and sustained chest pain. An electrocardiogram (ECG) will usually show ST-segment-elevation.
Standard: Health

Staphylococcus aureus bloodstream infection origin code N

752251 | Value Domain | Australian Commission on Safety and Quality in Health Care
A code set representing whether a patient episode of Staphylococcus aureus bloodstream infection (SABSI) is healthcare associated or community-acquired.
Standard: Health

Staphylococcus aureus methicillin susceptibility indicator

754394 | Property | Australian Commission on Safety and Quality in Health Care
An indicator of whether the Staphylococcus aureus bloodstream infection (SABSI) organism is susceptible to oxacillin or methicillin (cefoxitin).
Standard: Health

Stillbirth Clinical Care Standard

766607 | Indicator Set | Australian Commission on Safety and Quality in Health Care
The Australian Commission on Safety and Quality in Health Care has developed these indicators to support health service organisations to monitor implementation of the care described in the Stillbirth Clinical Care Standard (ACSQHC, 2022). The indicators included in this specification are a tool to support local clinical quality improvement and may be used to support other quality assurance and peer review activities.The goal of the standard is to:Reduce unwarranted clinical variation in the prev...
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 2a-Proportion of women assessed for clinical risk factors for fetal growth restriction at their first antenatal appointment at the hospital and the outcomes of the risk assessment documented in their medical record

766642 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 3a-Proportion of pregnant women who reported smoking who were provided with advice on smoking cessation, offered a referral to a smoking cessation service, and/or nicotine replacement therapy if clinically indicated

766646 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 3b- Proportion of women who gave birth who demonstrated their understanding of safe maternal going-to-sleep position at an antenatal visit from 28 weeks gestation

766648 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 3c- Proportion of women who gave birth who reported from 28 weeks gestation that they knew how to monitor their fetal movements and what to do if they were concerned about a change in their fetal movements

766650 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 5a- Evidence of local arrangements to enable timely assessment and appropriate care for women presenting with concerns about changes in fetal movements

766719 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 5b-Median time from when women report that they first noticed a change in fetal movements to when they contacted a clinician or healthcare service

766722 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 6a-Proportion of women who had a planned birth who received written and verbal information on the potential benefits and harms of planned birth, including the timing of intervention

766724 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 6b-Proportion of women who had a planned birth before 39 weeks gestation whose medical record documents the reason(s) for intervention

766726 | Indicator | Australian Commission on Safety and Quality in Health Care
Qualified: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 6c-Proportion of women with singleton pregnancies who had a planned birth before 39 weeks gestation

766728 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 7a-Proportion of clinicians who provide bereavement care to parents who have experienced a stillbirth who have completed an evidence-based bereavement care professional development program

766750 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 8a-Proportion of stillbirths reviewed by the healthcare service for potential contributing factors and classified according to the Perinatal Society of Australia and New Zealand classification system

766752 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Stillbirth Clinical Care Standard: 9a-Evidence of local arrangements to support the provision of bereavement care in line with the Clinical Practice Guideline for Care Around Stillbirth and Neonatal Death and Sands Australian Principles of Bereavement Care

766754 | Indicator | Australian Commission on Safety and Quality in Health Care
Standard: Australian Commission on Safety and Quality in Health Care

Surgical prophylaxis

624364 | Outcome Area | Australian Commission on Safety and Quality in Health Care
If a patient having surgery requires prophylactic antibiotics, the prescription is made in accordance with the current version of the Therapeutic guidelines: antibiotic (Antibiotic Expert Group 2014) (or local antibiotic formulary that aligns with the current Therapeutic guidelines: antibiotic), and takes into consideration the patient’s clinical condition.
Standard: Health

Prev 1 2 3 5 Next
Page size: